english.prescrire.org > Spotlight > 100 most recent > Prescrire is taking action at the European level


Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

Prescrire is taking action at the European level

Via its policy advocacy, Prescrire acts as a force for change in health policies, first and foremost in the interest of patients. Summaries of three such actions undertaken at the European level were published in Prescrire International's July-August issue.

European legislation on orphan drugs and paediatric drugs

  • Prescrire has contributed to a public consultation organised by the European Commission prior to a revision of this legislation.

The European health-data space

  •  Prescrire took part in a public consultation by the European Commission aimed at establishing a legal framework for digital health data and services.

Access to EMA documents

  • A video conference was held between the European Medicines Agency (EMA) and Prescrire to discuss the delays in dealing with our requests for access to documents.

Summaries available for download below.

©Prescrire 1 July 2022


"European legislation on orphan drugs and paediatric drugs" Prescrire International 2022; 31 (239): 193. Subscribers only.

"The European health-data space" Prescrire International 2022; 31 (239): 193-194. Subscribers only.

"Access to EMA documents" Prescrire International 2022; 31 (239): 194. Subscribers only.


Enjoy full access to Prescrire International, and support independent information

Share on  Facebook Share on  Twitter

For more information:

Advancing healthcare policy
in Europe, a chronological
recap of actions

Advancing healthcare policy.
Actions presented by theme

Read more:

All the subjects in
Prescrire's Spotlight
Free >